Skip to main content
. 2021 Sep 13;8(2):e001776. doi: 10.1136/openhrt-2021-001776

Table 5.

Comparison of the baseline and angiographic characteristics according to the occurrence of any DOCE versus no DOCE

No DOCE (n=56) DOCE (n=33) P value*
Age (years) 64.5±9.8 67.1±9.9 ns
Males (%) 51 (91) 27 (82) ns
Presentation (%)
 Chronic coronary syndrome 37 (66) 21 (64) ns
 Acute coronary syndrome 19 (34) 12 (36) ns
Cardiovascular risk factors (%)
 Arterial hypertension (%) 40 (71) 27 (82) ns
 Diabetes mellitus (%) 9 (16) 15 (45) 0.02
 Dyslipidaemia (%) 41 (73) 29 (88) ns
 Current smoking (%) 29 (52) 20 (61) ns
 Previous MI (%) 29 (52) 13 (40) ns
 Previous CABG (%) 5 (9) 7 (12) ns
Antithrombotics (%)
 Aspirin 55 (98) 33 (100) ns
 Clopidogrel 36 (64) 23 (70) ns
 Ticagrelor 8 (14) 6 (18) ns
 Prasugrel 7 (12) 8 (24) ns
 Oral anticoagulant 3 (3.4) 0 (0.0)
 Access (%)
 Radial 45 (80) 29 (88) ns
 Femoral 11 (20) 4 (12) ns
Culprit vessel (%)
 Left anterior descending 14 (25) 10 (30) ns
 Left circumflex 15 (27) 5 (15) ns
 Right coronary artery 26 (46) 19 (58) ns
Type of in-stent restenosis (%)
 (1)Focal 17 (30) 7 (21) ns
 (2) Diffuse 20 (36) 11 (33) ns
 (3) Proliferative 12 (21) 7 (21) ns
 (4) Occlusive 3 (7) 8 (24) 0.02

Data are mean (SD) or number (percentage), as appropriate.

*P values were based on Student’s t-tests, Mann-Whitney U tests, as appropriate.

CABG, coronary artery bypass; DOCE, device-oriented composite endpoint; MI, myocardial infarction; ns, not significant.